| 1 |
许 锐，陈前军. 人性化医疗与循证医学[J]. 医学与哲学，2019, 40(23): 5-7, 10.
|
| 2 |
李幼平，李 静，孙 鑫，等. 循证医学在中国的发展：回顾与展望[J]. 兰州大学学报：医学版，2016, 42(1): 25-28.
|
| 3 |
Wang JY, Jin XJ. Evidence-based medicine in China[J]. Chronic Dis Transl Med, 2019, 5(1): 1-5.
|
| 4 |
Evidence-based medicine working group. Evidence-based medicine：A new approach to teaching the practice of medicine[J]. JAMA, 1992, 268(17): 2420-2425.
|
| 5 |
Sackett DL, Rosenberg WM, Gray JA, et al. Evidence based medicine：what it is and what it isn′t[J]. BMJ, 1996, 312(7023): 70-72.
|
| 6 |
O′Sullivan JW, Albasri A, Koshiaris C, et al. Diagnostic test guidelines based on high-quality evidence had greater retes of adherence: a meta-epidemiological study[J]. J Clin Epidemiol, 2018, 103: 40-50.
|
| 7 |
Kelly MP. The need for a rationalist turn in evidence-based medicine[J]. J Eval Clin Pract, 2018, 24(5): 1158-1165.
|
| 8 |
Spence JD. The need for clinical judgement in the application of evidence-based medicine[J]. BMJ Evid Based Med, 2019: doi: 10.1136/bmjebm-2019-111300. |
| 9 |
Jada G, Hamilton JG, Lillie SE, et al. What is a good medical decsion? A research agenda guided by perspectives from multiple stakeholders[J]. J Behav Med, 2017, 40(1): 52-68.
|
| 10 |
Dolan JG, Veazie PJ. Harnessing expert judgment to support clinical decisions when the evidence base is weak[J]. Med Decis Making, 2019, 39(1): 74-79.
|
| 11 |
刘哲然. 从经验医学、循证医学到精准医学的演变及评价[J]. 医学与哲学，2017, 38(10B): 81-84.
|
| 12 |
Armitage J, Baigent C, Barnes E, et al. Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials[J]. Lancet, 2019, 393(11): 407-415.
|
| 13 |
刘 俊. 正确运用循证医学证据指导临床实践[J]. 医学与哲学，2019, 40(23): 15-18.
|
| 14 |
Fanaroff AC, Califf RM, Windecker S, et al. Levesls of evidence supporting American College of Cardiology/American Heart Association and European Society of Cardiology Guidelines, 2008-2018[J]. JAMA, 2019, 321: 1069-1080.
|
| 15 |
Herrera-Perez D, Haslam A, Crain T, et al. A comprehensive review of randomized clinical trials in three medical journals reveals 396 medical reversals[J]. Elife, 2019, 8: e45183.
|
| 16 |
Huo Y, Li J, Qin X, et al. Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China: the CSPPTrandomized clinical trial[J]. JAMA, 2015, 313*(13): 1325-1335.
|
| 17 |
Emdn CA, Odutayo A, Hsiao AJ, et al. Association between randomized trial evidence and global burden of disease: cross sectional study(epidemiological study of randomized trials-ESORT)[J]. BMJ, 2015, 350: h117.
|
| 18 |
Rabinstein AA, Brinjikji W, Kallmes DF. Equipoise in clinical trials：angst and progress[J]. Circ Res, 2016, 119(7): 798-800.
|
| 19 |
Scott IA. Filling the Glass of Evidence-Based Medicine[J]. Intern Med J, 2020, 50(1): 15-16.
|
| 20 |
任成山，林 辉，杨仕明. 结核病的流行特征与耐多药的窘迫及其策略[J/CD]. 中华肺部疾病杂志(电子版), 2019, 12(3): 269-274.
|
| 21 |
任成山，王关嵩，钱桂生. 慢性阻塞性肺疾病的成因及其治疗的困惑与希望[J/CD]. 中华肺部疾病杂志(电子版), 2019, 12(2): 127-141.
|
| 22 |
任成山，林 辉，杨仕明，等. 冠状病毒及新型冠状病毒肺炎防控策略[J/CD]. 中华肺部疾病杂志(电子版), 2020, 13(1): 1-5.
|
| 23 |
关于印发新型冠状病毒肺炎诊疗方案(试行第七版)的通知.
URL
|
| 24 |
Wan Y, Shang J, Graham R, et al. Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus[J]. J Virol, 2020, 94(7): e00127-20.
|
| 25 |
20200608-COVIDv19-sitrep-140.pdf
URL
|
| 26 |
李少峰，兰智慧，张元兵，等. 循证医学时代探讨名老中医经验传承模式的关键点[J]. 时珍国医国药，2017, 28(4): 930-931.
|
| 27 |
Li L, Fu HQ. China′s health care system reform: Progress and prospects[J]. Int J Health Plann Manage, 2017, 32(3): 240-253.
|
| 28 |
Djulbegovic B, Guyatt GH. Progress in evidence-based medicine: a quarter century on[J]. Lancet, 2017, 390(10092): 415-423.
|
| 29 |
Kim K, Lee CJ, Shim CY, et al. Statin and clinical outcomes of primary prevention in individuals aged>75 years: The SCOPE-75 study[J]. Atherosclerosis, 2019, 284: 31-36.
|
| 30 |
Ouchi Y, Sasaki J, Arai H, et al. Ezetimibe lipid-lowering trial on prevention of atherosclerotic cardiovascular disease in 75 or older(EWTOPIA 75)[J]. Circulation, 2019, 140(12): 992-1003.
|